Drugs / SKYVaricella®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07415252 | Jul 2026 → Feb 2027 expected | chickenpox | SK Bioscience Co., Ltd. | Recruiting | No outcome recorded |
News releases announcing trial results or a regulatory action · 4
| Date | Issuer | Release |
|---|---|---|
| 2026-07-09 | SK Bioscience Co., Ltd. | Regulatory SK bioscience Reaffirms Global GMP Excellence by Completing WHO Review Through Documentary Assessment skbioscience.com ↗
SK bioscience has demonstrated its world-class manufacturing and quality management capabilities after successfully completing the World Health Organization (WHO)´s periodic Good Manufacturing Practice (GMP) inspection through a documentary assessment without requiring an on-site inspection. |
| 2025-09-02 | SK Bioscience Co., Ltd. | Regulatory SK bioscience Submits IND for Phase 3 Clinical Trial of 2-Dose Varicella Vaccine skbioscience.com ↗ |
| 2024-03-21 | SK Bioscience Co., Ltd. | Regulatory SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Vaccine Market skbioscience.com ↗
SKYVaricella®, its varicella vaccine, has obtained marketing authorization in Mexico. |
| 2019-12-11 | SK Bioscience Co., Ltd. | Regulatory SK bioscience’s Varicella Vaccine Obtains World’s 2nd WHO PQ Certification skbioscience.com ↗
SK bioscience announced on the 11th that the company has obtained the WHO PQ certification for its varicella vaccine, ‘SKYVaricella®.´ |
All press releases naming this drug 4 releases
| Date | Issuer | Release |
|---|---|---|
| 2026-07-09 | SK Bioscience Co., Ltd. | SK bioscience Reaffirms Global GMP Excellence by Completing WHO Review Through Documentary Assessment skbioscience.com ↗ |
| 2025-09-02 | SK Bioscience Co., Ltd. | SK bioscience Submits IND for Phase 3 Clinical Trial of 2-Dose Varicella Vaccine skbioscience.com ↗ |
| 2024-03-21 | SK Bioscience Co., Ltd. | SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Vaccine Market skbioscience.com ↗ |
| 2019-12-11 | SK Bioscience Co., Ltd. | SK bioscience’s Varicella Vaccine Obtains World’s 2nd WHO PQ Certification skbioscience.com ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SKYVaricella | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07415252 ↗ |
| Modality | Vaccine | “live attenuated varicella virus vaccine” NCT07415252 ↗ |
| Route | Subcutaneous | “two subcutaneous injections” NCT07415252 ↗ |